Mereo BioPharma Group plc - ADR (MREO)
Market Open
11 Sep, 15:16
$
0. 27
+0.03
+12.0605%
$
40.64M Market Cap
- P/E Ratio
- Div Yield
1.42M Volume
0 Eps
$ 0.24
Previous Close 
Want to track MREO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Mereo BioPharma Group plc - ADR (MREO) Statistics
Valuation metrics
Market Cap 40.64M
Enterprise value 10.82M
Trailing P/E (ttm) -1.37
Forward P/E -8.49
PEG ratio -0.02
Price/Sales (ttm) 94.59
Price/Book (mrq) 1.4
Enterprise Value/Revenue 22.14
Enterprise Value/EBITDA -0.33
Overview
Shares outstanding 798.08M
Float 572.33M
Shares short 6.51M
% Held by insiders 0.01%
% Held by institutions 0.48%
Average volume (10 days) 1.33M
Average volume (90 days) 1.31M
Price summary
52-Week low 0.2
52-Week high 2.37
Beta 0.38
50-Day moving average 0.3
200-Day moving average 0.33
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -71.4%
Operating margin -75.31%
Operational effectiveness
Return on assets -0.81%
Return on equity -0.75%
Income Statement
Revenue (ttm) 500K
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -1%
Gross profit (ttm) 367K
EBITDA -35.58M
Net income to common (ttm) -35.71M
Diluted EPS (ttm) -0.17
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 36.22M
Total cash per share (mrq) 0.19
Total debt (mrq) 202K
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 5.88%
Book value per share (mrq) 0.18
Cash Flow
Cash flow statement -33.93M
Levered free cash flow (LFCF) -41.88M
